Meanwhile, patients with COVID-19 with lower expression of most IRs presented with the absence of CD8+ T cells and worse prognosis, indicating that IR might shape the clinical characteristics of COVID-19 through an immune activation-induced negative feedback mechanism. The gene discussed is CD8A; the disease is COVID-19.